Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Recent patents describe new anticoagulants

Nov. 6, 2006

MediciNova acquires antithrombic agents from Meiji Seika Kaisha

Nov. 6, 2006

Phase I study for i.v. formulation of Portola's ADP receptor antagonist

Nov. 3, 2006

Platrol, a safe sustained release antiplatelet drug

Nov. 2, 2006

Novel P2Y12 receptor antagonists emerge from Pfizer R&D

Oct. 27, 2006

Human thrombin shows noninferiority to bovine thrombin in general surgery

Oct. 20, 2006

NovoSeven approved for acquired hemophilia

Oct. 18, 2006

Novel agents for thrombotic disorders reported in recent Pfizer and Fournier patents

Oct. 18, 2006

Phase I study begins for next-generation anticoagulant M-118

Oct. 13, 2006

Treatment begins in second phase III trial of cangrelor in PCI

Oct. 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...